期刊文献+

唑来膦酸联合外科手术治疗骨质疏松性椎体压缩骨折的疗效及对骨代谢活力的影响 被引量:2

Effect of Zoledronic Acid Combined with Surgery on Osteoporotic Vertebral Compression Fracture and Its Effect on Bone Metabolism Vitality
下载PDF
导出
摘要 目的:探究唑来膦酸联合外科手术治疗骨质疏松性椎体压缩骨折(OVCF)的疗效及对骨代谢活力的影响。方法:选取2019年6月~2020年6月在某院就诊的98例骨质疏松性椎体压缩骨折患者为研究对象,按照随机数字表法分为对照组和观察组各49例,对照组给予经皮椎体后凸成形术(PKP)治疗,观察组在对照组的基础上另给予唑来膦酸治疗,对比分析两组治疗效果。结果:术后3个月、术后6个月,观察组骨密度与Ⅰ型前胶原氨基末端肽(PⅠNP)、骨碱性磷酸酶(BALP)水平高于对照组,β-胶原特殊序列(β-CTX)、抗酒石酸酸性磷酸酶(TRACP)水平与视觉模拟法(VAS)、Oswestry功能障碍指数问卷(ODI)评分均低于对照组,差异有统计学意义(P<0.05)。结论:对OVCF患者采用外科手术联合唑来膦酸,与单手术治疗相对比,其可以提升患者骨密度,稳定患者骨代谢指标的稳定性,同时有利于降低患者疼痛程度,改善患者腰椎功能。 Objective:To explore the efficacy of zoledronic acid combined with surgery in the treatment of osteoporotic vertebral compression fracture(OVCF)and its effect on bone metabolism activity.Methods:98 patients with osteoporotic vertebral compression fracture in a hospital from June 2019 to June 2020 were selected as the research object,and divided into two groups according to the random number table method.The control group(n=49)was treated with percutaneous kyphoplasty(PKP),and the observation group was treated with zoledronic acid on the basis of the control group.Results:At 3 and 6 months after operation,the bone mineral density,type I procollagen amino terminal peptide(PⅠNP)and bone alkaline phosphatase(BALP)levels in the observation group were higher than those in the control group,while the levels ofβ-collagen specific sequence(β-CTX),tartrate resistant acid phosphatase(TRACP),and the scores of VAS and Oswestry dysfunction index questionnaire(ODI)were significantly lower than those in the control group,with statistical significance(P<0.05).Conclusion:Compared with single operation,surgery combined with zoledronic acid in OVCF patients can improve bone mineral density,stabilize the stability of bone metabolism indexes,reduce the pain degree and improve lumbar function at the same time.
作者 刘婷婷 王枫淼 李显博 Liu Tingting;Wang Fengmiao;Li Xianbo(Department of Endocrinology,Nanyang Central Hospital,Nanyang 473000;Nanyang Orthopaedic Hospital,Nanyang 473000;Department of Orthopedics,Nanyang Central Hospital,Nanyang 473000)
出处 《数理医药学杂志》 CAS 2022年第4期591-593,共3页 Journal of Mathematical Medicine
关键词 唑来膦酸 经皮椎体后凸成形术 骨质疏松性椎体压缩骨折 骨代谢 疼痛程度 zoledronic acid percutaneous kyphoplasty osteoporotic vertebral compression fracture bone metabolism degree of pain
  • 相关文献

参考文献10

二级参考文献88

  • 1胡成栋,刘曦,周玉军,刘法敬,李东风,霍喜卫,李海涛,刘吉祥.椎体成形治疗中聚甲基丙烯酸甲酯骨水泥的应用[J].中国组织工程研究,2013,17(21):3823-3830. 被引量:6
  • 2杨惠林,顾晓晖,陈亮,陆俭,毛海青,孟斌,牛国旗,赵刘军,唐天驷.后凸成形术治疗骨质疏松性脊柱骨折的选择性与个体化[J].中国医学科学院学报,2005,27(2):174-178. 被引量:37
  • 3Wang G, Yang H, Chen K. Osteoporotic vertebral compression fractures with an intravertebral cleft treated by percutaneous balloon kyphoplasty[ J]. J Bone Joint Surg Br, 2010, 92:1553 - 1557.
  • 4Mao H, Zou J, Geng D, et al. Osteoporotic vertebral fractures without compression : key factors of diagnosis and initial outcome oftreatment with cement augmentation [ J ]. Neuroradiology, 2012, 54:1137 - 1143.
  • 5Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [ J ]. N Engl J Med, 2007, 356 : 1809 - 1822.
  • 6Black DM, Reid IR, Boonen S, et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [ J]. J Bone Miner Res ,2012,27:243 - 254.
  • 7Black DM, Reid 1R, Cauley JA, et al. The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT) [ J]. J Bone Miner Res,2015,30:934 - 944.
  • 8Lyles KW, Col6n-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture[ J]. N Engl J Med ,2007,357 : 1799 - 1809.
  • 9Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment : the Fracture Intervention Trial Long-term Extension ( FLEX ) : a randomized trial[ J]. JAMA,2006 ,296 :2927 - 2938.
  • 10Bone HG, Hosking D, Devogelaer JP, et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women[J]. N Engl J Med ,2004,350 : 1189 - 1199.

共引文献302

同被引文献30

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部